Edition:
India

Marisa Taylor

Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources

21 Oct 2020

CHICAGO/WASHINGTON AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness in a study participant, four sources told Reuters.

EXCLUSIVE-U.S. trial of AstraZeneca COVID-19 vaccine may resume this week -sources

21 Oct 2020

CHICAGO/WASHINGTON, Oct 20 AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness, four sources told Reuters.

EXCLUSIVE-AstraZeneca U.S. COVID-19 vaccine trial may resume as soon as this week -sources

20 Oct 2020

CHICAGO/WASHINGTON, Oct 20 AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness, four sources told Reuters.

Exclusive: FDA faults quality control at Lilly plant making Trump-touted COVID drug

15 Oct 2020

(This Oct. 13 story corrects to show that the federal government, not Eli Lilly, made the decision to pause a clinical trial of the company’s antibody drug, paragraph 10) | Video

Exclusive: FDA widens U.S. safety inquiry into AstraZeneca coronavirus vaccine - sources

02 Oct 2020

WASHINGTON The U.S. Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc's COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists, three sources familiar with the details told Reuters. | Video

Exclusive: Top adviser steps aside from FDA COVID-19 vaccine reviews over potential conflict

24 Sep 2020

A physician who heads the influential U.S. Food and Drug Administration vaccine advisory committee recused herself from the panel's review of COVID-19 vaccines because of her role overseeing a clinical trial for Moderna Inc's candidate, her spokeswoman told Reuters.

Pfizer vaccine trial bets on early win against coronavirus, documents show

18 Sep 2020

Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters that describe how the trial is being run.

World News